Literature DB >> 8454438

Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel.

A M Yinnon1, G A Morali, A Goren, B Rudensky, M Isacsohn, J Michel, C Hershko.   

Abstract

We describe our experience with 73 patients diagnosed with brucellosis during the years 1979-91 at two Jerusalem hospitals: Hadassah Mount Scopus (37 patients from 1979-1984) and Shaare Zedek (36 patients from 1979-1991). The patients included 32 children less than 14 years old and 41 adults; 70 of the patients were non-Jews. In all cases the pathogen was Brucella melitensis. The high proportion of children and the equal sex distribution was quite different from the age and sex distribution of brucellosis in Western countries where it is more common in adult males, and similar to that reported from other near-Eastern countries where household dairy products, and not occupational exposure, are the most common source of infection. The short duration of disease (< 2 weeks) prior to diagnosis in 70% of the patients is attributed to the ready availability of appropriate medical care, and a very high index of suspicion for brucellosis in the Jerusalem non-Jewish population. Abdominal symptoms were more common in adults, whereas enlarged lymph nodes and liver, skin rash and pharyngitis were more frequently observed in children. Some of these differences may be attributed to the very short duration of disease in most children at the time of presentation. Combination therapy with tetracycline-streptomycin or tetracycline-rifampin yielded superior results as compared with single-drug treatment in terms of early defervescence and relapse rates. The present experience underlines the importance of endemic brucellosis which still represents a significant public health problem in children and adults in Mediterranean countries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8454438

Source DB:  PubMed          Journal:  Isr J Med Sci        ISSN: 0021-2180


  7 in total

1.  Brucella sero-prevalence and modifiable risk factors among predisposed cattle keepers and consumers of un-pasteurized milk in Mbarara and Kampala districts, Uganda.

Authors:  George Nasinyama; Edward Ssekawojwa; John Opuda; Patrice Grimaud; Eric Etter; Alban Bellinguez
Journal:  Afr Health Sci       Date:  2014-12       Impact factor: 0.927

2.  Neurobrucellosis Mimicking Neurotuberculosis.

Authors:  Koushik Handattu; Nalini Bhaskaranand; Sandesh Bailur Kini
Journal:  Indian J Pediatr       Date:  2018-03-28       Impact factor: 1.967

3.  Human brucellosis in a nonendemic country: a report from Germany, 2002 and 2003.

Authors:  S Al Dahouk; K Nöckler; A Hensel; H Tomaso; H C Scholz; R M Hagen; H Neubauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-07       Impact factor: 3.267

Review 4.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

5.  Human brucellosis in Macedonia - 10 years of clinical experience in endemic region.

Authors:  Mile Bosilkovski; Ljiljana Krteva; Marija Dimzova; Ivan Vidinic; Zaklina Sopova; Katerina Spasovska
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

Review 6.  A Systematic Review and Meta-Analysis of Epidemiology and Clinical Manifestations of Human Brucellosis in China.

Authors:  Rongjiong Zheng; Songsong Xie; Xiaobo Lu; Lihua Sun; Yan Zhou; Yuexin Zhang; Kai Wang
Journal:  Biomed Res Int       Date:  2018-04-22       Impact factor: 3.411

7.  Cervical Lymph Nodes as a Selective Niche for Brucella during Oral Infections.

Authors:  Kristine von Bargen; Aurélie Gagnaire; Vilma Arce-Gorvel; Béatrice de Bovis; Fannie Baudimont; Lionel Chasson; Mile Bosilkovski; Alexia Papadopoulos; Anna Martirosyan; Sandrine Henri; Jean-Louis Mège; Bernard Malissen; Jean-Pierre Gorvel
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.